Sign in to view content

Interim Results and Key Learnings from an Ongoing Phase 2 Study of Encapsulated Cell Therapy Compared to Aflibercept in Patients With Wet AMD

Szilárd Kiss, MD

Video
Published 2016

Related

Aflibercept 8 mg in Diabetic Macular Edema: 156-Week Results From the PHOTON Extension Study
Eric W Schneider, MD
Updates from the Field
2025
Differences in Surgical Performance in Peeling the ILM for Macular Holes Between Fellows-in-Training and Experienced Vitreoretinal Surgeons
Robert Gizicki, MD, FRCSC, DABO
Annual Meeting Talks
2016
Association Between DRSS Changes and Visual/ Anatomic Outcomes in Patients With Moderately Severe to Severe NPDR: Post Hoc Analysis of PANORAMA
Diana V Do, MD, FASRS
Annual Meeting Talks
2022

Category: AMD-Neovascular

See more